CLEVELAND - Sept. 13, 2018 - TelAve -- Recognizing the lack of funding for pediatric medical device development, PediaVascular held a product pitch competition during the Pediatric & Adult Interventional Cardiac Symposium on September 6, in Las Vegas. Five teams of pediatric cardiologists presented their concepts to a panel of interventional cardiology experts. The winning concept was titled Deflectable Hybrid Sheath from a team at Our Lady's Children's Hospital in Crumlin, Ireland. PediaVascular awarded the team an unrestricted $25,000 grant to continue development efforts. The award also included complimentary consultations with regulatory, reimbursement, intellectual property, legal and business experts to assist in product commercialization.

More on TelAve News

• From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
• AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth
• Matecrypt Observes South American Cryptocurrency Adoption Surge Amid Economic Shifts
• Assent Uncovers Over 695 Unique PFAS Across Global Supply Chains as Regulations Increase
• Cryptocurrency Quarterly Trading Volume Surpasses $15 Trillion Record High as BrazilNex Acknowledges Industry 'Growing Pains' Amid Market Speculation

About PediaVascular: PediaVascular is a social venture formed in 2010 to address the lack of pediatric medical devices. In collaboration with fifty pediatric cardiologists PediaVascular developed a series of angiography catheters, introducers and guide wires specifically for children. They are the first and only to receive FDA clearance for pediatric use. To date, over 15,000 babies have been treated globally with PediaVascular's devices.

http://www.pediavascular.com